Several big pharma companies pledged to more tightly screen the doctors they pay to pimp their drugs to other medical professionals. The news comes after a major ProPublica investigation revealed the pill makers were paying princely sums to some docs with splotchy backgrounds. [More]
pfizer
38,000 More Smelly Bottles Of Lipitor Recalled
By 11.1.10
Pfizer is recalling 38,000 more bottles of Lipitor because the bottles smell musty. [More]
191,000 Bottles Of Lipitor Recalled Because Of Musty Odor
By 10.8.10
Though Pfizer apparently initiated a recall of its popular cholesterol fighting drug Lipitor (aka Atorvastatin) in August, it only came to the public attention this week. Regardless, a total of 191,000 90-pill bottles of the drug have been recalled from pharmacies in the U.S. and Canada. [More]
Kiddie Viagra Could Earn Patent Extension For Pfizer
By 7.28.10
Viagra for kids? That sounds… well, wrong. But apparently, low doses of the erectile dysfunction drug can help children stricken by a rare lung disorder. It could also earn Pfizer a six-month extension on the patent for its blue-chip brand. [More]
Viagra, Cialis Users Too Busy Doin' It To Use Condoms
By 7.6.10
Judging by the Viagra and Cialis ads on TV, users of these drugs spend their time playing novelty covers of “Viva Las Vegas” in the garage with their buddies or taking baths outdoors with their wives in separate claw-foot tubs. But no, apparently men take these pills so they can have sex, which they’re doing a lot of; oh, and they’re also catching a lot of STDs. [More]
Female Answer To Viagra Just Can't Stand Up To Testing Says FDA
By 6.17.10
Sad news for the world of gettin-it-on today: A drug that had been intended as a female analog to Viagra has not only not shown promise in tests, but has actually demonstrated some quite non-sexy side effects. [More]
Top 10 Crappiest CEOs (According To Their Employees)
By 10.27.09
Glassdoor released its report of the 50 lowest-rated CEOs as determined by employee reviews on its site. I scractched out all the companies you don’t care about and ended up with this list of the 10 Crappiest CEOs (of consumer-facing compaines) (according to their employees)…
Recent Class Action Lawsuits: Are You Eligible?
By 5.22.09
We’ve heard about quite a few recent class-action settlements that you just might be eligible for, as well as cute little baby suits still looking for claimants. Products included: energy drinks, name-brand prescription drugs, and zombie microwaves.
Pfizer Offers Free Medication To Unemployed Or Uninsured Patients
By 5.14.09
It’s hard for journalists (and bloggers) to resist a story that they can entitle “Free Viagra,” and pharmaceutical company Pfizer knows it. This recent publicity stunt is still newsworthy even without that headline, because of its purpose, and the problem for drug companies that it illustrates.
Why Do These Commercials For Chantix Not Mention The Drug? At All?
By 2.17.09
Our sister publication Consumer Reports Health has posted a new video in their AdWatch series, which examines direct-to-consumer pharmaceutical advertising. This time they’re examining some “stealth” advertising for the quit-smoking drug Chantix.
By 1.26.09
../../../..//2009/01/26/lipitor-shilling-drug-maker-pfizer-has/
Lipitor-shilling drug maker Pfizer has announced that they will be buying rival Wyeth for $68 billion. [WSJ Health Blog]
Boner Drug Ads To Run Exclusively During Programs Targeted To Adults?
By 12.10.08
Tired of your kids asking you what “erectile dysfunction” is? You’re not alone.
New Lipitor Ads Mercifully Free Of Fake Doctors
By 9.2.08
Well, it seems that Pfizer is ready to move on from that embarrassing “Dr. Jarvik is not actually licensed to practice medicine” kerfuffle back in February. The company pulled its Lipitor spots after Congress became very interested in whether or not the ads were misleading the public into believing that Dr. Jarvik was qualified to offer medical advice — and that he was really rowing that boat. Now, theWall Street Journal has a tantalizing preview of the new “Dr. Jarvik Free” Lipitor ad. The spot features a regular person named John — a heart attack survivor who urges you to learn from his example and be more proactive about controlling your cholesterol (with Lipitor, damn it! Lipitor!).
Round 12: Diebold Vs Pfizer
By 3.27.08
Pfizer hires stunt doubles to row for their not-a-physician (former) pitchman Dr. Robert Jarvik and this severely upsets Congress. They also don’t want you to use cheaper generics. And produce potentially misleading and sketchy commercials about Celebrex. And they also make car sick medicine for dogs.
Say Goodbye To Dr. Jarvik As He and His Stunt Double Row Into The Sunset
By 2.27.08
Weary of all the “fake rowing” controversy, Pfizer has canned Dr. Robert Jarvik (the inventor of the Jarvik artificial heart) as a spokesperson for their blockbuster cholesterol drug, Lipitor.
Congress Asks Pfizer: Why Is Dr. Jarvik Qualified To Pitch Lipitor?
By 1.9.08
Dr. Robert Jarvik is the inventor of the Jarvik artificial heart, right? You know that because he’s the pitch-man for Lipitor, a heavily advertised cholesterol drug. Have you ever stopped to ask yourself why inventing an artificial heart qualifies the man to pitch a drug?
Pfizer Launches Campaign To Warn Users Away From Generic Competitor
By 11.5.07
Pfizer is in panic mode about its rapid decline in Lipitor sales—in the last 18 months, it has dropped from 40% of the market for cholesterol-lowering drugs to 30%, and likely to drop further—so it’s launched a big media-blitz to convince people not to switch to simvastatin, the generic version of its name-brand competitor, Zocor. Zocor was more expensive than Lipitor, so Pfizer had nothing to worry about for years—but then Zocor lost its patent protection last year, and now doctors are switching patients from Lipitor over to Zocor’s generic twin to save money.
Controversial Ad Implies Celebrex Is As Safe As OTC Painkillers
By 4.10.07
A new ad for Celebrex, a prescription painkiller related to Vioxx, has come under fire for implying that Celebrex is as safe as non-prescription painkillers such as ibuprofen (Advil, Motrin) and naproxen (Aleve.) A consumer group has written a letter to the FDA requesting that they ban the ad, claiming that it contains “false or misleading statements.”
“The overall purpose of the ad is to make it appear, contrary to scientific evidence, that the cardiovascular dangers of Celebrex are not greater than those of any of the other Nsaid painkillers,” the letter said, referring to nonsteroidal anti-inflammatory drugs. “Further, it asserts that certain gastrointestinal problems are, if anything, less frequent with Celebrex than with two popular over-the-counter (OTC) painkillers.”
The ad, which is two-and-a-half minutes long (Pfizer was the only sponsor of the program on which it aired), can be viewed at Celebrex.com. The ad marks Celebrex’s return to advertising after a two year hiatus following Vioxx’s withdrawal from the market due to dangerous cardiovascular side-effects.
